Manish Kuchakulla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Manish Kuchakulla has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Ranjith Ramasamy
Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA
7 shared publications Hriday P. Bhambhvani
Department of Urology New York‐Presbyterian Hospital New York New York USA
4 shared publicationsAaron A. Gurayah
Department of Urology New York‐Presbyterian Hospital New York New York USA
3 shared publications- James A. Kashanian
Department of Urology, Weill Cornell Medicine, New York, New York
3 shared publications John M. Masterson
Department of Urology Weill Cornell Medical Center New York New York USA
3 shared publicationsManish Narasimman
Department of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA
3 shared publications
Latest Publications
Preoperative Total Testicular Volume as a Predictor of Total Motile Sperm Count Improvement Following Microsurgical Varicocelectomy
Background: Varicocelectomy has been shown to improve semen parameters in men with infertility; however, not all men experience improvement. Identifying preoperative predictors of semen parameter improvement is necessary for counseling and treatment planning. Objective: To determine if preoperative total testicular volume is associated with improved total motile sperm count (TMSC) after microsurgical varicocelectomy and to establish an optimal volume threshold for predicting clinical outcomes. Materials and Methods: We retrospectively reviewed 110 men who underwent microsurgical varicocelectomy for infertility between January 2017 and May 2024. Inclusion criteria were adult men with preoperative TMSC t ‐tests, chi‐squared tests, multivariable logistic regression, and receiver operating characteristic (ROC) curve analysis. Results: Of the 110 men, 56 (51%) demonstrated improvements in TMSC category. Men who experienced improvement had higher preoperative total testicular volume (33.0 mL vs. 23.4 mL, p < 0.001). ROC curve analysis identified a total testicular volume threshold of ≥25.5 mL, which was associated with a 12‐fold increased odds of improvement (OR 12.0, 95% CI: 2.6–77.5, p = 0.003). In multivariable analysis, age, BMI, procedure laterality, varicocele grade, and preoperative FSH and total testosterone levels were not independently associated with postoperative improvement in TMSC. Discussion and Conclusions: Preoperative total testicular volume is a strong predictor of improvement in TMSC following microsurgical varicocelectomy. These findings support the use of testicular volume in preoperative evaluation.
Preoperative Total Testicular Volume as a Predictor of Total Motile Sperm Count Improvement Following Microsurgical Varicocelectomy
Background: Varicocelectomy has been shown to improve semen parameters in men with infertility; however, not all men experience improvement. Identifying preoperative predictors of semen parameter improvement is necessary for counseling and treatment planning. Objective: To determine if preoperative total testicular volume is associated with improved total motile sperm count (TMSC) after microsurgical varicocelectomy and to establish an optimal volume threshold for predicting clinical outcomes. Materials and Methods: We retrospectively reviewed 110 men who underwent microsurgical varicocelectomy for infertility between January 2017 and May 2024. Inclusion criteria were adult men with preoperative TMSC t ‐tests, chi‐squared tests, multivariable logistic regression, and receiver operating characteristic (ROC) curve analysis. Results: Of the 110 men, 56 (51%) demonstrated improvements in TMSC category. Men who experienced improvement had higher preoperative total testicular volume (33.0 mL vs. 23.4 mL, p < 0.001). ROC curve analysis identified a total testicular volume threshold of ≥25.5 mL, which was associated with a 12‐fold increased odds of improvement (OR 12.0, 95% CI: 2.6–77.5, p = 0.003). In multivariable analysis, age, BMI, procedure laterality, varicocele grade, and preoperative FSH and total testosterone levels were not independently associated with postoperative improvement in TMSC. Discussion and Conclusions: Preoperative total testicular volume is a strong predictor of improvement in TMSC following microsurgical varicocelectomy. These findings support the use of testicular volume in preoperative evaluation.
- 21 August 2025
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 37 (12) , 1015-1016
Response to Comment on: Comparative outcomes of intralesional collagenase injection for Peyronie’s disease: acute vs. stable phase treatment
- 21 August 2025
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 37 (12) , 1015-1016
Response to Comment on: Comparative outcomes of intralesional collagenase injection for Peyronie’s disease: acute vs. stable phase treatment
- 12 August 2025
- Published by Wiley in BJU International
- Vol. 136 (6) , 1064-1070
Impact of microsurgical varicocelectomy on sperm capacitation and birth outcomes
Objective: To assess the impact of microsurgical subinguinal varicocelectomy on sperm capacitation, semen parameters, pregnancy rates, and live birth outcomes in men with clinical varicoceles. Patients and Methods: We retrospectively reviewed 260 consecutive men with clinical varicoceles who underwent a microsurgical subinguinal varicocelectomy procedure by a single surgeon from January 2019 to March 2024. Of these, 46 men had pre‐ and postoperative semen analyses and sperm capacitation tests. The primary outcome measure was change in the sperm capacitation score (Cap‐Score™; Androvia LifeSciences, Mountainside, NJ, USA). Secondary outcome measures included change in semen parameters, change in probability of generating a pregnancy (PGP), pregnancy rates, and live birth rates. Results: Among all 46 patients, there was an improvement in median sperm concentration (21.9 vs 30.0 million/mL; P < 0.01), mean total motile sperm count (TMSC; 33.9 vs 49.5 million; P = 0.04), mean sperm capacitation as measured by Cap‐Score (23.6% vs 27.7%; P < 0.01), and mean PGP (27.4% vs 34%; P < 0.01) after varicocelectomy. Of the 33 couples trying to conceive, 24 (72.7%) achieved a live birth or ongoing clinical pregnancy after varicocelectomy; however, 13 of these 24 couples (54.1%) utilised in vitro fertilisation. A normal postoperative sperm concentration and Cap‐Score were associated with a 60% chance of achieving pregnancy via natural conception or intrauterine insemination (IUI). Conclusion: Significant improvements in sperm concentration, TMSC, Cap‐Score, and PGP were observed at 3 months after surgery. Patients with a normal post‐varicocelectomy Cap‐Score and semen concentration had the highest probability of conception naturally or through IUI.
- 12 August 2025
- Published by Wiley in BJU International
- Vol. 136 (6) , 1064-1070
Impact of microsurgical varicocelectomy on sperm capacitation and birth outcomes
Objective: To assess the impact of microsurgical subinguinal varicocelectomy on sperm capacitation, semen parameters, pregnancy rates, and live birth outcomes in men with clinical varicoceles. Patients and Methods: We retrospectively reviewed 260 consecutive men with clinical varicoceles who underwent a microsurgical subinguinal varicocelectomy procedure by a single surgeon from January 2019 to March 2024. Of these, 46 men had pre‐ and postoperative semen analyses and sperm capacitation tests. The primary outcome measure was change in the sperm capacitation score (Cap‐Score™; Androvia LifeSciences, Mountainside, NJ, USA). Secondary outcome measures included change in semen parameters, change in probability of generating a pregnancy (PGP), pregnancy rates, and live birth rates. Results: Among all 46 patients, there was an improvement in median sperm concentration (21.9 vs 30.0 million/mL; P < 0.01), mean total motile sperm count (TMSC; 33.9 vs 49.5 million; P = 0.04), mean sperm capacitation as measured by Cap‐Score (23.6% vs 27.7%; P < 0.01), and mean PGP (27.4% vs 34%; P < 0.01) after varicocelectomy. Of the 33 couples trying to conceive, 24 (72.7%) achieved a live birth or ongoing clinical pregnancy after varicocelectomy; however, 13 of these 24 couples (54.1%) utilised in vitro fertilisation. A normal postoperative sperm concentration and Cap‐Score were associated with a 60% chance of achieving pregnancy via natural conception or intrauterine insemination (IUI). Conclusion: Significant improvements in sperm concentration, TMSC, Cap‐Score, and PGP were observed at 3 months after surgery. Patients with a normal post‐varicocelectomy Cap‐Score and semen concentration had the highest probability of conception naturally or through IUI.
- Open Access
- 1 January 2021
- Published by XMLink in The World Journal of Men's Health
- Vol. 39 (3) , 489-495
Evaluation of SARS-CoV-2 in Human Semen and Effect on Total Sperm Number: A Prospective Observational Study
Best JC, et al. World J Mens Health. 2021 Jan;39:e12. https://doi.org/10.5534/wjmh.200192
- 1 January 2021
- Published by XMLink in The World Journal of Men's Health
- Vol. 39 (3) , 489-495
Open AccessEvaluation of SARS-CoV-2 in Human Semen and Effect on Total Sperm Number: A Prospective Observational Study
Best JC, et al. World J Mens Health. 2021 Jan;39:e12. https://doi.org/10.5534/wjmh.200192
- 1 January 2021
- Published by Elsevier in F&S Reviews
- Vol. 2 (1) , 32-42
Exogenous testosterone replacement therapy versus raising endogenous testosterone levels: current and future prospects
- 1 January 2021
- Published by Elsevier in F&S Reviews
- Vol. 2 (1) , 32-42
Exogenous testosterone replacement therapy versus raising endogenous testosterone levels: current and future prospects
- 1 January 2021
- Published by Elsevier in European Urology
- Vol. 79 (1) , 159-160
Re: The Effect of Antioxidants on Male Factor Infertility: The Males, Antioxidants, and Infertility (MOXI) Randomized Clinical Trial
- 1 January 2021
- Published by Elsevier in European Urology
- Vol. 79 (1) , 159-160
Re: The Effect of Antioxidants on Male Factor Infertility: The Males, Antioxidants, and Infertility (MOXI) Randomized Clinical Trial
- 28 May 2020
- Published by Springer Nature in World Journal of Urology
- Vol. 39 (4) , 1307-1311
The association between plant-based content in diet and testosterone levels in US adults
Purpose To evaluate the association between the plant-based content of diet and serum testosterone levels in men from the national health and nutrition examination survey (NHANES) database. Materials and methods Data on demographics, diet, and testosterone levels was acquired from the NHANES database. Using the food frequency questionnaire, an overall plant-based diet index (PDI) and a healthful plant-based diet index (hPDI) was developed. A higher score on PDI and hPDI indicates higher consumption of plant foods. Results A total of 191 participants were included, average age was 45 (30–60) years and average total testosterone level was 546.7 ± 254.7 ng/dL. The mean PDI and hPDI were 50.4 ± 6 and 50.8 ± 7.2, respectively. On multiple linear regression analysis, BMI and age significantly contribute to testosterone levels (p < 0.05); however, neither of the diet indexes significantly predicted serum testosterone levels (PDI: p = 0.446; and hPDI: p = 0.056). Conclusions In a well characterized national database, the plant-based diet index is unable to predict testosterone levels. Plant-based food content in diet is not associated with serum testosterone levels.
- 28 May 2020
- Published by Springer Nature in World Journal of Urology
- Vol. 39 (4) , 1307-1311
The association between plant-based content in diet and testosterone levels in US adults
Purpose To evaluate the association between the plant-based content of diet and serum testosterone levels in men from the national health and nutrition examination survey (NHANES) database. Materials and methods Data on demographics, diet, and testosterone levels was acquired from the NHANES database. Using the food frequency questionnaire, an overall plant-based diet index (PDI) and a healthful plant-based diet index (hPDI) was developed. A higher score on PDI and hPDI indicates higher consumption of plant foods. Results A total of 191 participants were included, average age was 45 (30–60) years and average total testosterone level was 546.7 ± 254.7 ng/dL. The mean PDI and hPDI were 50.4 ± 6 and 50.8 ± 7.2, respectively. On multiple linear regression analysis, BMI and age significantly contribute to testosterone levels (p < 0.05); however, neither of the diet indexes significantly predicted serum testosterone levels (PDI: p = 0.446; and hPDI: p = 0.056). Conclusions In a well characterized national database, the plant-based diet index is unable to predict testosterone levels. Plant-based food content in diet is not associated with serum testosterone levels.
- 1 May 2020
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 33 (3) , 311-317
A systematic review and evidence-based analysis of ingredients in popular male testosterone and erectile dysfunction supplements
The objective was to study available evidence for ingredients of popular over-the-counter testosterone and erectile dysfunction (ED) supplements. The top 16 male testosterone and 16 ED supplements in the USA were identified from the most popular online retailers: A1 Supplements, Amazon, Vitamin Shoppe, and Walmart. In total, 37 ingredients were identified and PUBMED online database was reviewed for randomized-controlled trials (RCT) studying their efficacy. Ingredients were categorized based on evidence quantity using an adapted version of the American Heart Association scoring system. In total, 16 ingredients from testosterone supplements and 21 from ED supplements were identified. Tribulus, Eurycoma longifolia, Zinc, L-arginine, Aspartate, Horny goat weed, and Yohimbine were most common. In all, 105 RCTs studying the identified ingredients were found. No whole supplement products have published RCT evidence. 19% of ingredients received an A grade for strong positive evidence with net positive evidence in two or more RCTs. In total, 68% received C or D grades for contradicting, negative, or lacking evidence. Overall, 69% of ingredients in testosterone supplements and 52% of ingredients in ED supplements have published RCT evidence. Many male supplements claim to improve testosterone or ED parameters; however, there is limited evidence, which should be considered when counseling patients.
- 1 May 2020
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 33 (3) , 311-317
A systematic review and evidence-based analysis of ingredients in popular male testosterone and erectile dysfunction supplements
The objective was to study available evidence for ingredients of popular over-the-counter testosterone and erectile dysfunction (ED) supplements. The top 16 male testosterone and 16 ED supplements in the USA were identified from the most popular online retailers: A1 Supplements, Amazon, Vitamin Shoppe, and Walmart. In total, 37 ingredients were identified and PUBMED online database was reviewed for randomized-controlled trials (RCT) studying their efficacy. Ingredients were categorized based on evidence quantity using an adapted version of the American Heart Association scoring system. In total, 16 ingredients from testosterone supplements and 21 from ED supplements were identified. Tribulus, Eurycoma longifolia, Zinc, L-arginine, Aspartate, Horny goat weed, and Yohimbine were most common. In all, 105 RCTs studying the identified ingredients were found. No whole supplement products have published RCT evidence. 19% of ingredients received an A grade for strong positive evidence with net positive evidence in two or more RCTs. In total, 68% received C or D grades for contradicting, negative, or lacking evidence. Overall, 69% of ingredients in testosterone supplements and 52% of ingredients in ED supplements have published RCT evidence. Many male supplements claim to improve testosterone or ED parameters; however, there is limited evidence, which should be considered when counseling patients.